Companies: 10,795·Total market cap: $144.5T
Microbot Medical Inc.

Microbot Medical Inc.

MBOTNASDAQHealthcare● Active
$1.82
$-0.02(-1.09%)
Market Cap$82938186
P/E Ratio
52W High$4.67
52W Low$1.6

Microbot Medical Inc. (MBOT) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

mbot · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Microbot Medical Inc. (MBOT) measures how much investors pay for each dollar of the company's trailing earnings. MBOT's current PE ratio of N/A is calculated by dividing its stock price of $1.82 by its TTM earnings per share of -$0.21.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2026 est. EPS $-0.29
Based on 2 analysts
EPS (TTM)
-$0.21
TTM · diluted EPS
PEG Ratio
-0.20
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Microbot Medical Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2006 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Instruments & Supplies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Microbot Medical Inc.
Microbot Medical Inc.You
MBOT
$83MN/A-$0.21
Clene Inc.
Clene Inc.
CLNN
$55MN/A-$2.65
Context Therapeutics Inc.
Context Therapeutics Inc.
CNTX
$157MN/A-$0.38
Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc.
CRDL
$121MN/A-$0.39
DocGo Inc.
DocGo Inc.
DCGO
$54MN/A-$1.84
InspireMD, Inc.
InspireMD, Inc.
NSPR
$38MN/A-$0.66
Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc.
ORMP
$149M1.84x$1.55

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 10 of 20 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-0.29
2024-12-31
FY2024
$-0.73
2023-12-31
FY2023
$-1.05
2022-12-31
FY2022
$-1.81
2021-12-31
FY2021
$-1.59
2020-12-31
FY2020
$-1.29
2019-12-31
FY2019
$-1.70
2018-12-31
FY2018
$-0.81
2017-12-31
FY2017
$-0.85
2016-12-31
FY2016
$-10.14

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Microbot Medical Inc. (MBOT) measures how much investors pay for each dollar of the company's trailing earnings. MBOT's current PE ratio of N/A is calculated by dividing its stock price of $1.82 by its TTM earnings per share of -$0.21.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.82 ÷ -$0.21 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

MBOT pe ratio · 6 questions

MBOT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.82 and TTM EPS of -$0.21. Data sourced from Financial Modeling Prep via MBOT's SEC 10-K and 10-Q filings.

MBOT PE ratioWhat is MBOT PE ratioCurrent PE ratio of MBOTMBOT PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Microbot Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09